周五盘中,医疗设备公司iRadimed Corporation(股票代码:IRMD)股价大涨7.59%,引发市场关注。这一显著涨幅与公司发布的超预期季度财报密切相关。
根据iRadimed最新公布的财报,截至6月30日的季度调整后每股收益达到49美分,显著高于分析师平均预期的44美分,也超过去年同期的42美分。公司营收同比增长13.8%,达到2041万美元,同样优于分析师预期的201万美元。这一出色的业绩表现成为推动股价上涨的主要动力。
值得注意的是,尽管iRadimed本季度股价曾下跌2.4%,但今年迄今为止已上涨6.1%。分析师对该公司保持乐观态度,目前平均评级为"买入"。华尔街对iRadimed未来12个月的目标价中位数为71.00美元,较上一次收盘价58.34美元高出约17.8%,显示出市场对公司未来发展前景的信心。这些积极因素共同推动了今日的显著涨幅。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.